Exelixis EXEL Contract Liabilities and Refund Liability
Contract Liabilities and Refund Liability at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:CustomerRefundLiabilityCurrent.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's contract liabilities and refund liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's contract liabilities and refund liability?
- Exelixis (EXEL) reported contract liabilities and refund liability of $65.89M in Q1 2026.
- How has Exelixis's contract liabilities and refund liability changed year-over-year?
- Exelixis's contract liabilities and refund liability increased by 13.9% year-over-year, from $57.84M to $65.89M.
- What is the long-term trend for Exelixis's contract liabilities and refund liability?
- Over 5 years (2020 to 2025), Exelixis's contract liabilities and refund liability has grown at a 23.7% compound annual growth rate (CAGR), from $20.68M to $59.9M.
- What does contract liabilities and refund liability mean?
- Money received for goods or services not yet delivered, plus potential future refund obligations.
- How do you interpret contract liabilities and refund liability?
- An increase suggests strong future performance obligations or potential product returns, while a decrease indicates the successful fulfillment of contract terms.
- How does contract liabilities and refund liability compare across companies?
- Common in commercial-stage biopharma; reflects the nature of product distribution agreements and revenue recognition policies.